Zobrazeno 1 - 10
of 10
pro vyhledávání: '"陈华鑫"'
Publikováno v:
Applied Chemical Industry; Sep2024, Vol. 53 Issue 9, p2029-2033, 5p
Publikováno v:
Journal of Jiangsu University (Natural Science Edition) / Jiangsu Daxue Xuebao (Ziran Kexue Ban). 2021, Vol. 42 Issue 2, p242-248. 7p.
Publikováno v:
Applied Chemical Industry; May2023, Vol. 52 Issue 5, p1530-1536, 7p
Publikováno v:
China Sciencepaper; Jun2022, Vol. 17 Issue 6, p589-594, 6p
Publikováno v:
Piezoelectrics & Acoustooptics; 2021, Vol. 43 Issue 5, p715-719, 5p
Publikováno v:
China Sciencepaper; 2019, Vol. 14 Issue 12, p1289-1293, 5p
Publikováno v:
Journal of Jiangsu University (Natural Science Edition) / Jiangsu Daxue Xuebao (Ziran Kexue Ban); 2018, Vol. 39 Issue 3, p355-361, 7p
Autor:
Hua-Sin Chen, 陳華鑫
96
In the previous study, ethyl 4-(1-benzyl-1H-indazol-3-yl)benzoate (YD-3) was identified as the first selective non-peptide protease-activated receptor 4 (PAR4) antagonist. In order to develop noel PAR4 antagonist, YD-3 was selected as lead co
In the previous study, ethyl 4-(1-benzyl-1H-indazol-3-yl)benzoate (YD-3) was identified as the first selective non-peptide protease-activated receptor 4 (PAR4) antagonist. In order to develop noel PAR4 antagonist, YD-3 was selected as lead co
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/47453222969722384672
Autor:
Hua-Sin Chen, 陳華鑫
90
Ethyl 4-(1-benzyl-1H-indazol-3-yl)benzoate (YD-3) was first synthesized in our laboratory as a novel thrombin-receptor antagonist. In this study, YD-3 was used as a lead compound and a series of its derivatives (9a—9d, 10a—10n) were prepa
Ethyl 4-(1-benzyl-1H-indazol-3-yl)benzoate (YD-3) was first synthesized in our laboratory as a novel thrombin-receptor antagonist. In this study, YD-3 was used as a lead compound and a series of its derivatives (9a—9d, 10a—10n) were prepa
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/14381104464913170994
Publikováno v:
Jianzhu Cailiao Xuebao: Journal of Building Materials; Jun2015, Vol. 18 Issue 3, p415-420, 6p